Literature DB >> 12385011

Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer.

Hanna Mellin1, Liselotte Dahlgren, Eva Munck-Wikland, Johan Lindholm, Hodjattallah Rabbani, Mina Kalantari, Tina Dalianis.   

Abstract

The aim of our study was to investigate the physical state and the viral load of HPV-16 in tonsillar cancer and to correlate these findings with clinical outcome. To distinguish between integrated and episomal forms of HPV, 22 fresh-frozen tonsillar cancer samples were analysed by a method based on restriction enzyme cleavage, ligation and PCR (rliPCR). HPV-16 was detected in 11/22 and HPV-33 in 1/22 of the cancers, hence 12/22 (55%) of the tumours were HPV positive. Only extrachromosomal forms of HPV-16 were observed. Full-length episomal HPV was detected exclusively in 7/11 of the cancers, whereas both full-length and deleted forms of episomal HPV-16 were found in parallel in 2 other tumours. In 1 tumour only a deleted episomal form of HPV-16 was present. In the remaining HPV-16 positive tumour both full-length episomal as well as an 11 kbp PCR product were detected and if the 11 kbp product contained integrated HPV, or was off-size linearised episomal could not be determined. In 2 cervical cancer controls, HPV-16 was integrated and could be chromosome located. HPV-16 was quantified by real-time PCR and most tonsillar cancers contained between 10 to a few hundred copies of HPV per beta-actin. The 6 patients with tumour sections with > or =190 HPV-16 copies/beta-actin remained tumour free (p = 0.026) and had a better survival rate (p = 0.039) when compared to the 5 patients with tumours sections with < or =60 HPV-16 copies/beta-actin. In conclusion, HPV-16 is mainly episomal in tonsillar cancer. The viral load showed a wide distribution and the clinical outcome in our study was better when the HPV load was higher. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12385011     DOI: 10.1002/ijc.10669

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  62 in total

1.  HUMAN PAPILLOMAVIRUS ASSOCIATION WITH HEAD AND NECK CANCERS: UNDERSTANDING VIRUS BIOLOGY AND USING IT IN THE DEVELOPMENT OF CANCER DIAGNOSTICS.

Authors:  Katerina Strati; Paul F Lambert
Journal:  Expert Opin Med Diagn       Date:  2008-01-01

Review 2.  Human papillomavirus in head and neck tumors: epidemiological, molecular and clinical aspects.

Authors:  Jan Klozar; Ruth Tachezy; Eliška Rotnáglová; Eva Košlabová; Martina Saláková; Eva Hamšíková
Journal:  Wien Med Wochenschr       Date:  2010-06

Review 3.  Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination.

Authors:  Maura L Gillison
Journal:  J Adolesc Health       Date:  2008-10       Impact factor: 5.012

4.  Equivocal p16 immunostaining in squamous cell carcinoma of the head and neck: staining patterns are suggestive of HPV status.

Authors:  Zhongchuan Will Chen; Ilan Weinreb; Suzanne Kamel-Reid; Bayardo Perez-Ordoñez
Journal:  Head Neck Pathol       Date:  2012-07-17

5.  Trends in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma Incidence, Vermont 1999-2013.

Authors:  Adepitan A Owosho; Rashidah Wiley; Tessie Stansbury; Semiu O Gbadamosi; Jon S Ryder
Journal:  J Community Health       Date:  2018-08

6.  Detection of human papillomavirus (HPV) in clinical samples: evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas.

Authors:  William H Westra
Journal:  Oral Oncol       Date:  2014-06-02       Impact factor: 5.337

7.  Development and clinical evaluation of a highly sensitive DNA microarray for detection and genotyping of human papillomaviruses.

Authors:  Tae Jeong Oh; Chang Jin Kim; Suk Kyung Woo; Tae Seung Kim; Dong Jun Jeong; Myung Soon Kim; Sunwoo Lee; Hyun Sill Cho; Sungwhan An
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

Review 8.  HPV infections and tonsillar carcinoma.

Authors:  S Syrjänen
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

Review 9.  [HPV-associated tonsillar cancer. An update].

Authors:  J P Klussmann; S Dinh; O Guntinas-Lichius; C Wittekindt; S Weissenborn; U Wieland; H P Dienes; T Hoffmann; E Smith; L Turek; E J M Speel; H J Pfister
Journal:  HNO       Date:  2004-03       Impact factor: 1.284

Review 10.  HPV & head and neck cancer: a descriptive update.

Authors:  Peter K C Goon; Margaret A Stanley; Jörg Ebmeyer; Lars Steinsträsser; Tahwinder Upile; Waseem Jerjes; Manuel Bernal-Sprekelsen; Martin Görner; Holger H Sudhoff
Journal:  Head Neck Oncol       Date:  2009-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.